Allscripts Announces Increase To Stock Repurchase Program And Names Board Chairman
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) today announced that its Board of Directors has authorized management to repurchase an additional $200 million of Allscripts common stock, bringing the total repurchase authorization to $400 million. Since May 5, 2011, the Company has repurchased approximately $52 million of Allscripts common stock under its previously approved $200 million share repurchase program.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.